Eric Hyllengren's Insider Trades & SAST Disclosures
Eric Hyllengren's most recent trade in Atara Biotherapeutics Inc was a trade of 8,961 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Eric Hyllengren.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc | Eric Hyllengren | Former EVP, CFO & COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2025 | 8,961 | 2,656 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Eric Hyllengren | Former EVP, CFO & COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2025 | 1,900 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Eric Hyllengren | Former EVP, CFO & COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2025 | 543 | 160 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Eric Hyllengren | Former EVP, CFO & COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2025 | 496 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Eric Hyllengren | Former EVP, CFO & COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2025 | 460 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Eric Hyllengren | Former EVP, CFO & COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2025 | 381 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Eric Hyllengren | Former EVP, CFO & COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2025 | 350 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Eric Hyllengren | Former EVP, CFO & COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2025 | 331 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Eric Hyllengren | Former EVP, CFO & COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2025 | 262 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Eric Hyllengren | Former EVP, CFO & COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2025 | 154 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Eric Hyllengren | EVP, CFO and COO | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 03 Mar 2025 | 1,211 | 56,231 (0%) | 0% | 7.0 | 8,473 | Common Stock |
| Atara Biotherapeutics Inc | Eric Hyllengren | EVP, CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 34,050 | 57,442 (0%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Eric Hyllengren | EVP, CFO and COO | 18 Nov 2024 | 1,364 | 23,392 (0%) | 0% | 11.2 | 15,274 | Common Stock | |
| Atara Biotherapeutics Inc | Eric Hyllengren | EVP, CFO | 16 Aug 2024 | 1,041 | 24,785 (0%) | 0% | 6.6 | 6,901 | Common Stock | |
| Atara Biotherapeutics Inc | Eric Hyllengren | EVP, CFO | 16 Aug 2024 | 29 | 24,756 (0%) | 0% | 6.6 | 192 | Common Stock | |
| Atara Biotherapeutics Inc | Eric Hyllengren | EVP, CFO | 16 May 2024 | 28,648 | 645,671 (1%) | 0% | 0.6 | 17,676 | Common Stock | |
| Atara Biotherapeutics Inc | Eric Hyllengren | EVP, CFO | 04 Mar 2024 | 5,217 | 674,319 (1%) | 0% | 0.7 | 3,756 | Common Stock | |
| Atara Biotherapeutics Inc | Eric Hyllengren | EVP, CFO | 04 Mar 2024 | 1,462 | 679,536 (1%) | 0% | 0.7 | 1,054 | Common Stock | |
| Atara Biotherapeutics Inc | Eric Hyllengren | EVP, CFO | 08 Jan 2024 | 475,000 | 680,998 (1%) | 0% | 0 | Common Stock | ||
| Atara Biotherapeutics Inc | Eric Hyllengren | SVP, CFO | 16 May 2023 | 6,199 | 227,861 (0%) | 0% | 2.0 | 12,627 | Common Stock | |
| Atara Biotherapeutics Inc | Eric Hyllengren | SVP, CFO | 16 May 2023 | 1,719 | 226,142 (0%) | 0% | 2.0 | 3,503 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges